PMEPA1-Mediated Treg Cell Impairment Promotes Endometrial Stromal Invasion via Excessive PI3K/AKT Signaling in Endometriosis

Abstract

Objective

Although immune dysregulation is implicated in the pathogenesis of endometriosis (EMs), the specific role of prostate transmembrane protein androgen induced 1 (PMEPA1) in modulating the function of regulatory T cells (Tregs) remains inadequately understood. This study aimed to elucidate the regulatory mechanisms by which PMEPA1 influences the activity of Tregs, thereby facilitating the invasion of endometrial stromal cells (ESCs).

Methods

Single-cell RNA sequencing (scRNA-seq) was performed on matched ectopic ovarian lesions and eutopic endometria from 3 patients. Clinical specimens from patients with EMs and control subjects were examined for PMEPA1 expression. Primary human Tregs isolated from peripheral blood mononuclear cells were subjected to PMEPA1 overexpression (via plasmid) or knockdown (via siRNA). Modulation of the PI3K pathway was conducted via the activator 740Y-P or the inhibitor LY294002. The secretion of IL-10 and TGF-β by Tregs was quantified using an enzyme-linked immunosorbent assay. Ectopic ESCs cocultured with modified Tregs were assessed for their proliferation, migration, and invasion capabilities.

Results

scRNA-seq data revealed significant upregulation of PMEPA1 in Tregs from ectopic ovarian lesions compared with paired eutopic endometria. PMEPA1 expression was increased in the ectopic lesions and peritoneal fluid mononuclear cells of patients with EMs. Tregs overexpressing PMEPA1 demonstrated reduced secretion of IL-10 and TGF-β but exhibited hyperactivation of the PI3K/AKT signaling pathway. Treatment with LY294002 ameliorated the impairment in cytokine secretion. Coculture experiments with Tregs expressing high levels of PMEPA1 resulted in increased invasion, migration, and proliferation of ESCs.

Conclusion

PMEPA1 impairs Treg-mediated immunosuppression by hyperactivating the PI3K/AKT pathway, thereby facilitating the invasiveness of ESCs in EMs.

Keywords

Prostate transmembrane protein androgen induced 1 / Regulatory T cells / PI3K/AKT signaling / Endometriosis / Stromal cells

References

[1] Chapron C, Marcellin L, Borghese B, et al.. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol., 2019, 15(11): 666-682

[2] Hsu CF, Khine AA, Huang HS, et al.. The Double Engines and Single Checkpoint Theory of Endometriosis. Biomedicines., 2022, 10(6): 1403

[3] Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet., 2021, 397(10276839-852

[4] Vallve-Juanico J, Houshdaran S, Giudice LC. The endometrial immune environment of women with endometriosis. Hum Reprod Update., 2019, 25(5): 564-591

[5] Huang X, Wu L, Pei T, et al.. Single-cell transcriptome analysis reveals endometrial immune microenvironment in minimal/mild endometriosis. Clin Exp Immunol., 2023, 212(3): 285-295

[6] Quan Q, Wu J, Yu M, et al.. Immune micro-environment and drug analysis of peritoneal endometriosis based on epithelial-mesenchymal transition classification. Front Endocrinol (Lausanne)., 2022, 13: 1035158

[7] Tanaka Y, Mori T, Ito F, et al.. Exacerbation of Endometriosis Due To Regulatory T-Cell Dysfunction. J Clin Endocrinol Metab., 2017, 102(9): 3206-3217

[8] Li MQ, Wang Y, Chang KK, et al.. CD4+Foxp3+ regulatory T cell differentiation mediated by endometrial stromal cell-derived TECK promotes the growth and invasion of endometriotic lesions. Cell Death Dis., 2014, 5(10 e1436

[9] Berbic M, Hey-Cunningham AJ, Ng C, et al.. The role of Foxp3+ regulatory T-cells in endometriosis: a potential controlling mechanism for a complex, chronic immunological condition. Hum Reprod., 2010, 25(4900-907

[10] Podgaec S, Rizzo LV, Fernandes LF, et al.. CD4(+) CD25(high) Foxp3(+) cells increased in the peritoneal fluid of patients with endometriosis. Am J Reprod Immunol., 2012, 68(4): 301-308

[11] Olkowska-Truchanowicz J, Bocian K, Maksym RB, et al.. CD4(+) CD25(+) FOXP3(+) regulatory T cells in peripheral blood and peritoneal fluid of patients with endometriosis. Hum Reprod., 2013, 28(1): 119-124

[12] Khan KN, Yamamoto K, Fujishita A, et al.. Differential Levels of Regulatory T Cells and T-Helper-17 Cells in Women With Early and Advanced Endometriosis. J Clin Endocrinol Metab., 2019, 104(10): 4715-4729

[13] Huynh A, DuPage M, Priyadharshini B, et al.. Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability. Nat Immunol., 2015, 16(2): 188-196

[14] Fan MY, Turka LA. Immunometabolism and PI(3)K Signaling As a Link between IL-2, Foxp3 Expression, and Suppressor Function in Regulatory T Cells. Front Immunol., 2018, 9: 69

[15] Kitz A, de Marcken M, Gautron AS, et al.. AKT isoforms modulate Th1-like Treg generation and function in human autoimmune disease. EMBO Rep., 2016, 17(8): 1169-1183

[16] Itoh S, Itoh F. TMEPAI family: involvement in regulation of multiple signalling pathways. J Biochem., 2018, 164(3195-204

[17] Yang Y, Cheng T, Xie P, et al.. PMEPA1 interference activates PTEN/PI3K/AKT, thereby inhibiting the proliferation, invasion and migration of pancreatic cancer cells and enhancing the sensitivity to gemcitabine and cisplatin. Drug Dev Res., 2022, 83(1): 64-74

[18] Hirata H, Xu X, Nishioka K, et al.. PMEPA1 and NEDD4 control the proton production of osteoclasts by regulating vesicular trafficking. FASEB J., 2021, 35(2 e21281

[19] Funakubo N, Xu X, Kukita T, et al.. Pmepa1 induced by RANKL-p38 MAPK pathway has a novel role in osteoclastogenesis. J Cell Physiol., 2018, 233(4): 3105-3118

[20] Yang J, Yang L, Zhou Y, et al.. Molecular subtype of recurrent implantation failure reveals distinct endometrial etiology of female infertility. J Transl Med., 2025, 23(1): 792

[21] Piqué-Gili M, Andreu-Oller C, Mesropian A, et al.. Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC. JHEP Rep., 2024, 6(11 101212

[22] Zhang L, Wang X, Lai C, et al.. PMEPA1 induces EMT via a non-canonical TGF-β signalling in colorectal cancer. J Cell Mol Med., 2019, 23(53603-3615

[23] Huang H, Sun R, Xu Y, et al.. PMEPA1 promotes gastric cancer cell proliferation by regulating the ubiquitin-mediated degradation of 14-3-3σ and promoting cell cycle progression. Braz J Med Biol Res., 2024, 57 e13985

[24] Wang B, Zhong JL, Li HZ, et al.. Diagnostic and therapeutic values of PMEPA1 and its correlation with tumor immunity in pan-cancer. Life Sci., 2021, 277 119452

[25] Li J, Kong WM. PMEPA1 Serves as a Prognostic Biomarker and Correlates with Immune Infiltrates in Cervical Cancer. J Immunol Res., 2022, 2022: 4510462

[26] Sharad S, Ravindranath L, Haffner MC, et al.. Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer. Epigenetics., 2014, 9(6): 918-927

[27] Kakumani PK, Guitart T, Houle F, et al.. CSDE1 attenuates microRNA-mediated silencing of PMEPA1 in melanoma. Oncogene., 2021, 40(183231-3244

[28] Liu R, Zhou Z, Huang J, et al.. PMEPA1 promotes androgen receptor-negative prostate cell proliferation through suppressing the Smad3/4-c-Myc-p21 Cip1 signaling pathway. J Pathol., 2011, 223(5): 683-694

[29] Song M, Zhou B, Li B, et al.. PMEPA1 Stimulates the Proliferation, Colony Formation of Pancreatic Cancer Cells via the MAPK Signaling Pathway. Am J Med Sci., 2021, 362(3): 291-296

[30] Sauer S, Bruno L, Hertweck A, et al.. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A., 2008, 105(22): 7797-7802

[31] Shrestha S, Yang K, Guy C, et al.. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat Immunol., 2015, 16(2): 178-187

[32] Zhang G, Zheng G, Zhang H, et al.. MUC1 induces the accumulation of Foxp3(+) Treg cells in the tumor microenvironment to promote the growth and metastasis of cholangiocarcinoma through the EGFR/PI3K/Akt signaling pathway. Int Immunopharmacol., 2023, 118 110091

RIGHTS & PERMISSIONS

The Author(s), under exclusive licence to the Huazhong University of Science and Technology